A new light-based sensor can spot incredibly tiny amounts of cancer biomarkers in blood, raising the possibility of earlier and simpler cancer detection. The technology merges DNA nanotechnology, ...

A new highly sensitive light-based sensor can detect extremely low concentrations of cancer biomarkers in the blood.

Scientists have developed a powerful new sensor that uses light to detect extremely tiny signs of cancer in the blood, raising hopes for earlier diagnosis through a simple blood test. The technology ...

Please provide your email address to receive an email when new articles are posted on . The study will evaluate whether two multicancer early detection tests improve early detection of 10 solid tumors ...

Cancer affects millions of people around the world every year. Oftentimes, the signs and symptoms of cancer present themselves once the disease has advanced into its later stages, leaving many wishing ...

A four-biomarker blood panel of aminopeptidase N (ANPEP), polymeric immunoglobulin receptor (PIGR), CA19-9, and thrombospondin-2 (THBS2) enhanced the detection of pancreatic ductal adenocarcinoma ...

Fred Hutch Cancer Center is leading the newly launched Vanguard Study, a national study of a new type of blood test that screens for several different cancers called multi-cancer detection (MCD) tests ...

MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (Nasdaq: EXAS), a leader in cancer diagnostics, today announced the launch of the Cancerguard™ test, a new multi-cancer early detection (MCED) ...